Use of an anti-Hepatitis C Virus (HCV) IgG avidity assay to identify recent HCV infection

Journal of Clinical Microbiology

Volumn 48, Issue 9, 2010, Pages 3281-3287

  Gaudy Graffin, Catherine ^a,b   Lesage, Gérard ^b   Kousignian, Isabelle ^c   Laperche, Syria ^d   Girault, Annie ^d   Dubois, Frédéric ^b   Goudeau, Alain ^a,b   Barin, Francis ^a,b  

^a UNIVERSITÉ DE TOURS   (France)

^b CHU BRETONNEAU   (France)

^c AP HP   (France)

^d INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CHRONIC DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SEROLOGY; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODY AFFINITY; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; VIROLOGY; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 77956833695     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00303-10     Document Type: Article

References (20)

1. Calleri, G., G. Cariti, F. Gaiottino, F. G. De Rosa, O. Bargiacchi, S. Audagnotto, S. Quaglia, T. De Blasi, P. Romano, A. Traverso, G. Leo, R. Carbone, B. Del Mastro, M. Tinelle, P. Caramello, and G. Di Perri. 2007. A short course of pegylated interferon-alpha in acute HCV hepatitis. J. Viral Hepat. 14:116-121.
2. Chargelegue, D., B. T. Colvin, and C. M. O'Toole. 1993. A 7-year analysis of anti-Gag (p17 and p24) antibodies in HIV-1-seropositive patients with haemophilia: immunoglobulin G titre and avidity are early predictors of clinical course. AIDS 7:S87-S90.
3. Coppola, N., R. Pisapia, C. Marrocco, S. Martini, L. M. Vaterio, V. Messina, G. Tonziello, C. Sagnelli, P. Filippini, F. Piccinino, and E. Sagnelli. 2007. Anti-HCV IgG avidity index in acute hepatitis C. J. Clin. Virol. 40:110-115.
4. Coppola, N., R. Pisapia, G. Tonziello, A. Masiello, S. Martini, M. Pisaturo, V. Messina, C. Sagnelli, M. Macera, G. Signoriello, and E. Sagnelli. 2009. Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG avidity index. J. Clin. Virol. 46:222-229.
5. Esteban, J. I., S. Sauleda, and J. Quer. 2008. The changing epidemiology of hepatitis C virus infection in Europe. J. Hepatol. 48:148-162. (Pubitemid 350191999)
6. Grangeot-Keros, L., M. J. Mayaux, P. Lebon, F. Freymuth, G. Eugene, R. Stricker, and E. Dussaix. 1997. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J. Infect. Dis. 175:944-946.
7. Hedman, K., and S. A. Rousseau. 1989. Measurement of avidity of specific IgG for verification of recent primary rubella. J. Med. Virol. 27:288-292.
8. Inouye, S., A. Hasegawa, S. Matsuno, and S. Katow. 1984. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J. Clin. Microbiol. 20:525-529.
9. Jaeckel, E., M. Cornberg, H. Wedemeyer, T. Santantonio, J. Mayer, M. Zankel, G. Pastore, M. Dietrich, C. Trautwein, M. P. Manns, and the German Acute Hepatitis C Therapy Group. 2001. Treatment of acute hepatitis C with interferon alfa-2b. N. Engl. J. Med. 345:1452-1457.
10. Junker, A. K., and P. Tilley. 1994. Varicella-zoster virus antibody avidity and IgG-subclass patterns in children with recurrent chickenpox. J. Med. Virol. 43:119-124.
11. Kanno, A., and Y. Kazuyama. 2002. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection. J. Med. Virol. 68:229-233.
12. Klimashevskaya, S., A. Obriadina, T. Ulanova, G. Bochkova, A. Burkov, A. Araujo, S. L. Stramer, L. H. Tobler, M. P. Busch, and H. A. Fields. 2007. Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of anti-HCV immunoglobulin G avidity index. J. Clin. Microbiol. 45:3400-3403.
13. Lanotte, P., F. Dubois, S. Le Pogam, C. Guerois, B. Fimbel, Y. Bacq, Y. Gruel, A. Goudeau, and F. Barin. 1998. The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs. J. Infect. Dis. 178:556-559.
14. Papatheodoridis, G. V., J. K. Delladetsima, A. Katsoulidou, V. Sypsa, M. Albrecht, G. Michel, A. Hatzakis, and N. C. Tassopoulos. 1997. Significance of IgM anti-HCV core level in chronic hepatitis C. J. Hepatol. 27:36-41.
15. Santantonio, T., J. Wiegand, and J. T. Gerlach. 2008. Acute hepatitis C: current status and remaining challenges. J. Hepatol. 49:625-633.
16. Thomas, H. I., S. Wilson, C. M. O'Toole, C. M. Lister, A. M. Saeed, R. P. Watkins, and P. Morgan-Capner. 1996. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Clin. Exp. Immunol. 103:185-191.
17. Ward, K. N., W. Dhaliwal, K. L. Ashworth, E. J. Clutterbuck, and C. G. Teo. 1994. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody. J. Med. Virol. 43:367-372.
18. Wiegand, J., P. Buggisch, W. Boecher, S. Zeuzem, C. M. Gelbmann, T. Berg, W. Kauffmann, B. Kallinowski, M. Cornberg, E. Jaeckel, H. Wedemeyer, M. P. Manns, and German HEP-NET Acute HCV Study Group. 2006. Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study. Hepatology 43:250-256.
19. Wolter, T., C. Gassmann, V. Vetter, and G. Bauer. 1997. Avidity determination: utilization of a basic immunological mechanism allows improvement of the serodiagnosis of infections. Clin. Lab. 43:125-135.
20. Zaaijer, H. L., L. T. Mimms, H. T. Cuypers, H. W. Reesink, C. L. van der Poel, S. Taskar, and P. N. Lelie. 1993. Variability of IgM response in hepatitis C virus infection. J. Med. Virol. 40:184-187.